Sign in Create account

Fischer Medical Ventures Limited

Healthcare · Healthcare Equipment & Supplies

NSE: FISCHER BSE: 524743
₹33.55
▼ -0.13 (-0.39%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
36/100
Weak
Valuation
—/100
Expensive
Momentum
47/100
Neutral

QVM read Mixed signals Quality Weak, Valuation Expensive, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹2,196 Cr
PE (TTM)
Data unavailable.
Price to Book
6.5
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
6.83%
FII + DII, latest filed period
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
-1.0
Relative return vs Sector, qtr %
-14.1
Free Cash Flow
₹-69 Cr
as of Sept. 30, 2025
Industry median ₹-4 Cr (17 companies)
EPS Growth (YoY)
44.44%
as of June 30, 2026
Industry median 27.06% (10 companies)
Net Profit Growth (TTM)
-190.96%
as of June 30, 2026
Industry median 12.23% (8 companies)
Operating Revenue Growth (TTM)
-36.25%
as of June 30, 2026
Industry median 8.86% (8 companies)
Profit Growth (YoY)
249.62%
as of Dec. 31, 2024
Industry median 24.77% (9 companies)
Revenue Growth (YoY)
-84.10%
as of June 30, 2026
Industry median 12.25% (11 companies)
Current Ratio
2.50
as of March 31, 2026
Industry median 3.04 (17 companies)
Debt to Equity
0.04
as of March 31, 2026
Industry median 0.11 (12 companies)
Interest Coverage
-1.81
as of June 30, 2026
Industry median 12.12 (11 companies)
Net Margin
-485.32%
as of June 30, 2026
Industry median 5.41% (10 companies)
Operating Margin (EBIT)
-243.32%
as of June 30, 2026
Industry median 9.40% (11 companies)
Operating Margin (TTM)
-64.14%
as of June 30, 2026
Industry median 13.81% (11 companies)
Return on Assets
0.60%
as of March 31, 2025
Industry median 4.45% (10 companies)
Return on Capital Employed
0.31%
as of March 31, 2025
Industry median 8.85% (11 companies)
Return on Equity
0.63%
as of March 31, 2026
Industry median 2.26% (9 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

1 of 4 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.04)
  • No Return on equity is 15% or more (0.6%)

Ownership

3 of 4 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • No Promoter pledge is 5% of their holding or less and not rising (7.4% pledged)
  • Yes Insiders have not sold in the past 3 months (no open-market sale filed in the last 3 months)

Peer comparison

1 of 3 met
  • No 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

0 of 5 met
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-0.4%
Low 33.3500 · High 34.7000
1W return
-4.2%
Low 32.8500 · High 35.9900
1M return
-4.7%
Low 32.5000 · High 38.5000
52W return
-68.9%
Low 31.0500 · High 121.7000
Lifetime High ₹1160.9000 (Sept. 10, 2025)
Lifetime Low ₹31.2100 (June 9, 2026)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish0
Bearish6
5D
33.8
10D
34.0
20D
34.6
50D
35.8
100D
36.6
200D
37.9

Delivery and volume

Day avg. delivery
57.4%
Week avg. delivery
48.3%
Month avg. delivery
66.7%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

33.87
Pivot
First resistance34.38
Second resistance35.22
Third resistance35.73
First support33.03
Second support32.52
Third support31.68
Day RSI40.9
Day MFI33.3
Day MACD-0.80
Day MACD signal-0.86

Beta

1M1.52
3M0.65
1Y0.59
3Y0.40

Price change analysis

↓ -4.7%
Over 1 Month
LowHigh
32.5038.50
↓ -18.1%
Over 3 Months
LowHigh
32.5041.38
↓ -18.5%
Over 6 Months
LowHigh
31.0542.78
↓ -68.9%
Over 1 Year
LowHigh
31.05121.70
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹1 Cr
Net profit (June 30, 2026)
₹-4 Cr
Basic EPS (June 30, 2026)
₹-0.0500

Ranks #2 of 13 in Healthcare Equipment & Supplies by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Aug 2026
  • Promoter63.08%
  • FII/FPI5.57%
  • Other DII1.26%
  • Public30.09%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings increased from 62.15% to 63.08% in Aug 2026 qtr

Historical fii holding

FII/FPI holdings increased from 5.48% to 5.57% in Aug 2026 qtr

Historical mutual fund holding

Mutual funds holdings were unchanged at 0.00% in Aug 2026 qtr

All shareholding details →

Insider trading, SAST & pledges

All 2 insider trades, 9 SAST, 2 pledge events →

Latest insider trades

FiledPersonCategoryTypeQuantityValue
1 Apr 2026 SHANKAR VARADHARAJAN Promoter Buy 0 ₹0
6 Feb 2026 SHANKAR VARADHARAJAN Promoter Pledge 0 ₹109.59 Cr

All insider and SAST disclosures →

Deals (Bulk & Block)

All 13 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
22 Sep 2026 TRADE SOLVENT PRIVATE LIMITED Bulk Buy 6,436,907 32.9500 NSE
22 Sep 2026 L7 HITECH PRIVATE LIMITED Bulk Sell 6,436,907 32.9500 NSE
22 Sep 2026 L7 HITECH PRIVATE LIMITED Bulk Buy 305,000 32.9800 NSE
10 Apr 2023 ANAND MOHAN Bulk Sell 1,258 79.8000 BSE
30 Jun 2022 KETAN RASHIKLAL DOSHI Bulk Buy 900 66.6000 BSE
17 Jun 2022 KIRTAN JITENDRA BHAI PATEL Bulk Buy 996 79.9700 BSE
27 Dec 2021 RAVINDRADADAJIJILTE Bulk Sell 973 93.2700 BSE
27 Dec 2021 MOHAMMADZAHIDHUSSAIN Bulk Buy 1,000 93.2000 BSE
23 Aug 2021 ARUNKUMAR Bulk Buy 932 90.0700 BSE
9 Mar 2018 SURESH SABANNA ITKAL Bulk Buy 900 12.5000 BSE

All bulk and block deals →

Corporate Actions

Full history (2 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from Fischer Chemic Ltd. to FISCHER MEDICAL VENTURES LIMITED
—NAME_CHANGEName changed from Fischer Inorganics & Aromatics Ltd. to Fischer Chemic Ltd.

All corporate actions →

Board Meetings

View board meeting history →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
14 Aug 2026 Financial Results Yes
29 May 2026 Financial Results/Dividend Yes
30 Jan 2026 Financial Results Yes
28 Oct 2025 Financial Results/Other business matters Yes
14 Aug 2025 Financial Results Yes

Corporate Announcements

All 9 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
1 Oct 2026 AGM/EGM Fischer Medical Ventures Ltd - 524743 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
29 Sep 2026 AGM/EGM Fischer Medical Ventures Ltd - 524743 - Shareholder Meeting / Postal Ballot-Outcome of AGM
28 Sep 2026 Company Update Fischer Medical Ventures Ltd - 524743 - General Update
25 Sep 2026 Insider Trading / SAST Fischer Medical Ventures Ltd - 524743 - Closure of Trading Window
16 Sep 2026 Company Update Fischer Medical Ventures Ltd - 524743 - Chairman''s Message
9 Sep 2026 Company Update Fischer Medical Ventures Ltd - 524743 - Announcement under Regulation 30 (LODR)-Newspaper Publication
5 Sep 2026 Company Update Fischer Medical Ventures Ltd - 524743 - Announcement under Regulation 30 (LODR)-Newspaper Publication
4 Sep 2026 Company Update Fischer Medical Ventures Ltd - 524743 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
3 Sep 2026 Corp. Action Fischer Medical Ventures Ltd - 524743 - Record Date For E-Voting At AGM And Dividend

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Low financial leverage (Debt/Equity 0.04)
  • Healthy liquidity (Current Ratio 2.50)

Weaknesses

  • Low Return on Equity (0.6%)
  • Thin net profit margin (-485.3%)
  • Declining revenue YoY (-84.1%)

Opportunities

Data unavailable.

Threats

  • Down 68.9% over the past year
  • Weak interest coverage (-1.8x) -- limited cushion against rising rates

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Fischer Medical Ventures Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.